Event

Presentations

Welcome and scope of the conference

• Opening speech
  Willem Penning, European Commission DG SANCO
• Setting the scene – Views from the European Parliament
  Michèle Rivasi, MEP Greens

Session 1: Introduction, Horizontal topics, General outline

• Fundamentals of interaction with people
  Philip Chadwick, EMFields Ltd
• Basics of Risk Assessment
  Christopher Portier, US Center for Disease Control
• Exposure Assessment and Dosimetry – Aspects of Reliability
  Georg Neubauer, Austrian Institute of Technology
• Exposure Assessment for Epidemiological Studies
  Simon Mann, UK Health Protection Agency
• Report on Session 1
  Theodoros Samaras, Aristotle University of Thessaloniki, Greece

Session 2: The main sources of uncertainty in EMF health research and how they are addressed?

• Sources of uncertainty in epidemiological studies
  Anssi Auvinen, Radiation and Nuclear Safety Authority, Finland
• Laboratory studies
  Carmela Marino, Italian National Agency for New Technologies

Session 3: Current state of knowledge – Where are the areas of scientific consensus (consistency, coherence)

• Extremely Low Frequencies (ELF)
  Clemens Dasenbrock, Fraunhofer Institute for Toxicology and Experimental Medicine, Germany
• Radiofrequency in Experimental Studies
  Isabelle Lagroye, University of Bordeaux, France
• ELF, IF and Static Fields – Cancer and other Long-term Effects in Humans
  Kerstin Hug, Swiss Tropical Institute, Basel, Switzerland
• Areas of Scientific Consensus
  Leeka Kheifets, University of California, Los Angeles, USA
• Reproductive Health
  Jukka Juutilainen, University of Kuopio, Finland
• Acute Effects of RF EMF
  Peter Achermann, University of Zürich, Switzerland
• Self-reported symptoms, symptom attribution and terminology
  James Rubin, King’s College London, UK

Session 4: What are the areas of scientific inconsistency and knowledge gaps?

• Biological effects, basic interaction mechanisms of Extremely Low Frequencies
  Maria Rosaria Scarfi, CNR-Institute for Electromagnetic Sensing of Environment, Italy
• Knowns, uncertainties and gaps: Biological effects of radiofrequency fields
  Zenon Sienkiewicz, UK Health Protection Agency
• Cohort studies and other epidemiological evidence
  Joachim Schüz, International Agency for Research on Cancer, France
• Research gaps
  Christoffer Johansen, Danish Cancer Society
• Areas of scientific inconsistency and knowledge gaps: Acute effects
  Heikki Hämalainen, University of Turku, Finland
• Overview of new technologies
  Jørgen Bach Andersen, Aalborg University, Denmark
• New technologies in the sub- RFfrequency range
  Norbert Leitgeb, Graz University of Technology, Austria

Session 5: Lessons learned and recommendations for the future

• Critical issues in ELF/RF EMF research
  Martin Röösli, University of Basel, Switzerland
• Possible conclusions and perspectives for future research - epidemiology
  Maria Feychting, Karolinska Institutet, Sweden
• Possible Conclusions & Perspective for Future Research
  Niels Kuster, ITIS, Switzerland
• Comments - Lessons learned & recommendations
  Peter Wiedemann, Institüt für Technologie Karlsruhe, Germany
• Closing remarks
  Martin Seychell, Deputy Director General, DG SANCO